celecoxib has been researched along with Thymus Neoplasms in 1 studies
Thymus Neoplasms: Tumors or cancer of the THYMUS GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Six patients with thymic neoplasms were treated with capecitabine 1000 mg/m twice daily and celecoxib 200 mg twice daily, day 1 to day 14 on a 21-day cycle." | 1.48 | Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. ( Byron, E; Janisch, L; Salgia, R; Sharma, MR; Wood, K, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wood, K | 1 |
| Byron, E | 1 |
| Janisch, L | 1 |
| Salgia, R | 1 |
| Sharma, MR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Drug-drug Interaction Study of Capecitabine and Celecoxib in Patients With Advanced Solid Malignancies[NCT01705106] | Phase 1 | 21 participants (Actual) | Interventional | 2012-08-29 | Terminated (stopped due to The study was terminated early due to slow accrual.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for celecoxib and Thymus Neoplasms
| Article | Year |
|---|---|
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Celecoxib; Female; Follow-Up Stu | 2018 |